ロード中...

How do CARs work?: Early insights from recent clinical studies targeting CD19

Second-generation chimeric antigen receptors (CARs) are powerful tools to redirect antigen-specific T cells independently of HLA-restriction. Recent clinical studies evaluating CD19-targeted T cells in patients with B-cell malignancies demonstrate the potency of CAR-engineered T cells. With results...

詳細記述

保存先:
書誌詳細
主要な著者: Davila, Marco L., Brentjens, Renier, Wang, Xiuyan, Rivière, Isabelle, Sadelain, Michel
フォーマット: Artigo
言語:Inglês
出版事項: Landes Bioscience 2012
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3525612/
https://ncbi.nlm.nih.gov/pubmed/23264903
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.22524
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!